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As methods for analysis of biomolecular structure
and dynamics using nuclear magnetic resonance
spectroscopy (NMR) continue to advance, the result-
ing 3D structures, chemical shifts, and other NMR
data are broadly impacting biology, chemistry, and
medicine. Structure model assessment is a critical
area of NMRmethods development, and is an essen-
tial component of the process of making these struc-
tures accessible and useful to the wider scientific
community. For these reasons, the Worldwide Pro-
tein Data Bank (wwPDB) has convened an NMR Vali-
dation Task Force (NMR-VTF) to work with wwPDB
partners in developing metrics and policies for bio-
molecular NMR data harvesting, structure represen-
tation, and structure quality assessment. This paper
summarizes the recommendations of the NMR-VTF,
and lays the groundwork for future work in devel-
oping standards and metrics for biomolecular NMR
structure quality assessment.Structure 21, 1563–15TheWorldwide Protein Data Bank (wwPDB) (Berman et al., 2003,
2007) has convened several task forces to recommend metrics,
standards, and software for biomolecular structure quality
assessment. These include task forces providing recommenda-
tions for validating biomolecular structures determined by X-ray
crystallography (Read et al., 2011), cryo-electron microscopy
(Henderson et al., 2012), NMR, and small-angle X-ray or neutron
scattering (SAXS/SANS) (Trewhella et al., 2013). The delibera-
tions of these task forces are also important for defining critical
research areas in the field of biomolecular structure analysis,
and for guiding efforts of researchers developing their own struc-
ture validation platforms. Here we present the initial recommen-
dations of the NMR Validation Task Force (NMR-VTF). These
recommendations supplement those published by an earlier
commission addressing related problems of NMR structure rep-
resentation and interpretation (Markley et al., 1998).
NMR is now routinely used for determining 3D structures of
small (<20 kDa) proteins to high accuracy, often using largely
automated methods (Mao et al., 2011; Rosato et al., 2012;
Serrano et al., 2012). In favorable cases, structures of proteins
as large as 50 kDa or larger can be determined with good accu-
racy (Lange et al., 2012; Raman et al., 2010). It is critical to the
further development of the field to establish metrics and70, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1563
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derived structures. A wide variety of different data types and
methods are used by different groups to generate NMR struc-
tures. For this reason, it is important to define unifying and stan-
dardized approaches for defining the precision and accuracy of
NMR-derived biomolecular structures. This information is essen-
tial for appropriate use of these structures in biological research.
Several software packages have been developed that inte-
grate various tools for NMR structure quality assessment (Bhat-
tacharya et al., 2007; Doreleijers et al., 2012; Laskowski et al.,
1996; Nabuurs et al., 2003; Spronk et al., 2003; Vriend, 1990;
Tejero et al., 2013; Vuister et al., 2013). These analyses can pro-
vide useful information to experimentalists for improving the
interpretation of NMR data (e.g., allowing more accurate identi-
fication of NOESY peaks) and to users of the data by indicating
those parts of the structure that can be used to address specific
questions about structure and function. Although such software
suites are very useful, the field has not yet adopted uniformly
accepted metrics and standards for NMR structure quality
assessment.
The NMR-VTF recommends that certain well-developed
methods and software packages can form a basis for a stan-
dardized platform for protein NMR structure assessment. In
particular, the NMR-VTF recommends that existing tools devel-
oped for validation of X-ray diffraction-derived structures of bio-
macromolecules and their complexes (Read et al., 2011; Gore
et al., 2012) are also appropriate for NMR structures. NMR-spe-
cific software tools andmetrics that are already broadly adopted
by the NMR community can be used together with these knowl-
edge-based geometric validation methods to provide a first-
stage NMR structure validation platform.
However, further research and development is required to
address additional important issues of NMR structure validation
that are needed for a comprehensive platform. These include
validation of 3D structures against chemical shift, residual
dipolar coupling, chemical shift anisotropy, paramagnetic relax-
ation enhancement, small-angle X-ray scattering, and NOESY
peak list data, as well as assessing the impact of internal
dynamics and ensemble-averaging effects on the interpretation
of these NMR data. It is recognized that more extensive metrics
than those presented here will be required to fully capture the full
breadth of all these effects. Further work by the NMR-VTF in
consultation with the community is required in order to stan-
dardize these additional structure quality metrics so that they
can be broadly adopted by the wwPDB on behalf of the biolog-
ical NMR community. It is very important that the broader scien-
tific community has a voice in the evolution of standards and
conventions for validating biomolecular NMR structures. For
this reason, we have established an ‘‘NMR Community Discus-
sion Site,’’ at http://nmr-community.wwpdb.org.
Principal Recommendations
The NMR-VTF recommends that the depositors of biomolecular
NMR structures be encouraged to provide atomic coordinates
for all atoms in residues for which backbone and/or side-chain
resonance assignments have been determined. This would
include large internal loops, interdomain linkers,N-andC-terminal
regions, and purification tags, even where the structure in these
regions is ‘‘ill defined’’ (i.e., not well converged or not well defined1564 Structure 21, 1563–1570, September 3, 2013 ª2013 Elsevier Ltin terms of a unique conformation) by the ensemble. The concept
is that every residue for which some experimental data are avail-
able should be represented in the atomic coordinates. However,
asexplainedbelow, ill-defined regionsshouldbespecifically iden-
tified by the wwPDB through the use of software agreed upon by
the community, and these regions should be handled distinctly in
the structure quality assessment process. Notwithstanding these
recommendations, coordinates for regions of the structure that
the depositor feels are not reliable may be excluded from the
deposition at the discretion of the depositor.
The NMR-VTF further recommends that the wwPDB imple-
ment a standardized structure validation pipeline in three
phases.
Phase 1. Validation metrics that can be implemented easily
and immediately by the wwPDB by using existing software.
Phase 2. Validation metrics for which software/methods are
available but that need more assessment before standards
and conventions can be defined for the wwPDB.
Phase 3. Validation methods requiring further research over
the coming years.
The NMR-VTF has focused its initial efforts on validation of
protein structures determined primarily from NMR data. Further
work by the NMR-VTF is needed in order to establish recommen-
dations for validation of nucleic acids, carbohydrates, and other
biological structures determined primarily from NMR data.
Phase 1. Validation Metrics that Can Be Implemented
Easily by the wwPDB Using Existing Software
Existing software packages can be used to generate validation
reports for all submitted protein NMR structures. Software that
is freely accessible to the scientific community, and in general
use by the biomolecular NMR community, should be used for
generating these validation reports. These wwPDB NMR Struc-
ture Validation Reports should include four components: (1) a
report validating the completeness and global referencing of
chemical shift data, independent of 3D structure; (2) analysis
of ‘‘well-defined’’ versus ‘‘ill-defined’’ regions; (3) a knowledge-
based model validation report; and (4) a restraint-based
model-versus-data validation report, comparing each member
of the ensemble of NMRmodels to the available NMR restraints.
These validation reports should also be generated for all NMR
structures already in the PDB and distributed by wwPDB mem-
ber sites. It is recognized that as many of these structures do not
have chemical shift data and/or complete restraint data, these
validation reports for many of the archived NMR structures will
be incomplete. It is also recognized that some structures will
have poor validation analyses, often reflecting the early vintage
of some of the NMR structures in the archive. These validation
reports on the archived NMR structures are nonetheless valu-
able to the scientific community. Care should also be taken to
first identify and exclude from this analysis ‘‘averaged atomic
coordinates,’’ which do not correspond to physically reasonable
models. In the initial phase, these reports will be provided
primarily for protein structures, until similar recommendations
have been developed for nucleic acids and other biomolecular
NMR structures.
In certain cases, spectra may indicate the presence of two
or more structures in slow exchange on the chemical shiftd All rights reserved
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tein, or conformations distinguished by slow proline cis/trans
isomerization). In the event that two or more nontrivially distinct
NMR structures are generated for the biomolecule from distinct
restraint data, the two (or more) atomic coordinate sets should
be deposited and validated separately. An example of two struc-
tures that should be deposited and validated separately would
be one protein for which different coordinates have been deter-
mined for surface loops containing different proline (cis versus
trans) peptide-bond conformations.
Chemical Shift Data Validation Report. All new NMR structures
that are deposited in the PDB are now required to include the
chemical shift data used to determine the structure. The NMR-
VTF recommends that a Phase 1 NMR Structure Validation
Report include an analysis of the completeness of these chemi-
cal shift data for all assigned atoms, global reference correc-
tions, and a list of chemical shift outliers. Completeness of
assignments refers to the percentage of resonances (e.g., 1H,
13C, and 15N) for which assignments are reported, relative to
the number of potentially assignable atoms in the full-length pro-
tein construct, excluding highly exchangeable protons (e.g.,
N-terminal and Lys amino and Arg guanido groups, hydroxyl
hydrogens of Ser, Thr, and Tyr, and carboxyl hydrogens of Asp
and Glu, or the equivalent hydrogen atoms of nucleic acids)
and nonprotonated nitrogens and carbons (e.g., Pro N and
aromatic Cg). Backbone carbonyl carbons of peptide bonds
shall generally be included in the number of assignable atoms.
For the purpose of calculating assignment completeness per-
centages, the three hydrogens of a methyl group are counted
as one atom. If a single chemical shift has been assigned for a
diastereotopic pair, this same shift should be reported for both
hydrogen or methyl groups, unless it has been experimentally
established that it originates from only one of the two diastereo-
topic partners.
Standardized chemical shift completeness and global refer-
encing reports can be generated by using the same tools that
are used by the BioMagResBank (BMRB) (Ulrich et al., 2008),
including the assignment validation software suite (AVS) (Mose-
ley et al., 2004), linear analysis of chemical shifts (LACS) (Wang
et al., 2005; Wang and Markley, 2009), and SPARTA+ (Shen
and Bax, 2010). Additional tools that could be useful for valida-
tion of the integrity and accuracy of the chemical shift data,
and to identify unusual or outlier chemical shifts, include the
probabilistic approach for protein NMR assignment validation
(PANAV) (Wang et al., 2010), CheckShift (Ginzinger et al.,
2007), SHIFTX2 (Han et al., 2011), and validation of archived
chemical shifts through atomic coordinates (VASCO) (Rieping
and Vranken, 2010). The output of an appropriate subset of these
tools could be combined into a single consistent chemical shift
data validation report. As discussed below, it is premature to
include in this phase 1 report a validation of 3D structure models
on the basis of chemical shift data.
Well-Defined versus Ill-Defined Atoms or Residue Ranges. NMR
structure validation methods are generally applicable only to the
well-defined regions of the macromolecular structure. Atoms
that are not well defined in their atomic positions by the experi-
mental NMR data should not be included as part of the global
NMR structure validation. However, such ill-defined regions of
the structure may still be useful for expert applications, andStructure 21, 1563–15models for these regions generally will also be included in the
atomic coordinate file. Users of protein NMR structure models
need to be made aware of which atoms in the PDB coordinate
file are well defined in the NMR structure. For these reasons, it
is important that NMR structure coordinates are flagged in a
way that identifies well-defined and ill-defined residues and
atoms.
Solution NMR structures typically are represented as ‘‘ensem-
bles’’ of coordinate sets. Each member of the ensemble repre-
sents a single model that is consistent with the experimental
data. The distribution of models across the ensemble provides
insight into how well defined the structure is in different regions.
Well-defined regions are those that are precisely (although not
necessarily accurately) modeled across the ensemble. The ill-
defined parts of the structure may correspond to regions of a
molecule undergoing conformational dynamics, or may simply
reflect incompleteness of the restraining data.
The ensemble representation of molecular models is some-
times confusing to biologists attempting to use an NMR struc-
ture. Although each model in the ensemble is considered to be
a valid representation of the structure, the uncertainty in these
atomic coordinates is commonly assessed by statistical analysis
across the ensemble. However, for various reasons, the
ensemble representation does not provide a statistically sound
estimate of the precision of the atomic coordinates given uncer-
tainties of the experimental data (Andrec et al., 2007; Clore et al.,
1993; Snyder et al., 2005; Snyder and Montelione, 2005; Spronk
et al., 2003), nor does it provide a true estimate of conformational
dynamics. Nonetheless, the ensemble representation is the
current convention of the field for distinguishing those regions
of a structure that are well defined by the experimental data
from those that are ill defined. This distinction is critical for
appropriate quality assessment of NMR structures. Accordingly,
it is important that the ensemble information is conveyed in a
simple way to users of NMR structures.
Chemical shifts, residual dipolar couplings, relaxation rates,
and other NMR parameters that provide structural information
may be associated with ill-defined regions. Ill-defined regions
may also include transient structural information that is function-
ally important. For these reasons, it is recommended that atomic
coordinates be provided for all residues for which chemical shift
data are available, even though these coordinatesmay be impre-
cisely defined by the experimental data.
It is recognized that such ill-defined regions, which may be
flexibly disordered, are often biologically and/or biophysically
important, particularly in determining the biochemical functions
of macromolecules (Dyson and Wright, 2005; Dunker et al.,
2008). NMR can provide unique information about amplitudes
and timescales of dynamic fluctuations, which often contribute
to biomolecular function. These are important considerations
for the NMR-VTF in phases 2 and 3, as outlined below. Although
the convention of designating residues or atoms as ‘‘ill defined’’
is helpful for users of biomolecular structures, the terminology ‘‘ill
defined’’ should in no way be interpreted as devaluing the signif-
icance of these regions of the structure. Considering that flexibly
disordered regions of biomolecular structures are important
structural and functional features, and that methods for inter-
preting ensemble-averaged information in these regions of
the structure are still under development, the NMR-VTF70, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1565
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backbone and side-chain circular variance versus residue num-
ber for all residues for which atomic coordinates are provided.
Depositor Specification of Well-Defined and Ill-Defined Regions.
The NMR-VTF recommends that the wwPDB allow depositors to
specify regions of the biomolecular structure that are well
defined across the ensemble of NMR structures and those that
are ill defined. Tags for such designators have already been
developed by the wwPDB and are ready to be implemented as
part of PDB depositions.
Automated Analysis of Well-Defined and Ill-Defined Regions.
Although the initial designation of ill-defined regions can be pro-
vided by depositors, for the purposes of uniform structure quality
assessment, the wwPDB should adopt an automatedmethod for
defining those parts of the NMR structure that are well defined
and ill defined. Several algorithms and software packages are
available to make these assessments automatically. These
include methods based on (1) the locations of elements of sec-
ondary structure, (2) backbone dihedral angle circular variance
(Hyberts et al., 1992), and (3) variance matrix analysis (Bru¨nger
et al., 1993; Kelley et al., 1996, 1997; Kirchner and Gu¨ntert,
2011; Snyder and Montelione, 2005), including methods that
use maximum-likelihood superimposition based on principal
components analysis (Theobald andWuttke, 2006, 2008). Defini-
tions based on locations of elements of secondary structure
exclude irregular structures in proteins that may, in fact, be
well defined. Methods based on backbone dihedral angle circu-
lar variance (Hyberts et al., 1992) are very popular in the protein
NMR community, but do not provide information about long-
range order; that is, they cannot assess howwell defined subdo-
mains of the structure are with respect to one another.
The NMR-VTF recommends that the wwPDB adopt one of the
several software packages for discriminating between well-
defined and ill-defined regions of the protein structure. The
method adopted should include the ability to distinguish multiple
well-defined regions or ‘‘domains’’ that are not well defined with
respect to one another. Examples of these would include two
domains of well-defined atoms connected by an ill-defined
linker, or a well-defined domain and independent well-defined
helix, connected by an ill-defined linker. In these cases, each
of the corresponding subdomains can generally be identified
by distance variance matrix methods, and should be assessed
separately. The software package recommended for this anal-
ysis is CYRANGE (Kirchner andGu¨ntert, 2011); other similar soft-
ware tools have also been described in the literature (Bru¨nger
et al., 1993; Kelley et al., 1996, 1997; Snyder and Montelione,
2005) and may also be suitable for this purpose.
Representative NMR Structure. It is recognized that the user
community requires the designation of one NMR model from
the calculated ensemble, or derived from the ensemble, that is
a single representative of the solution structure. The NMR-VTF
recommends that the PDB identify the medoid model (Struyf
et al., 1997; Snyder et al., 2005; Tejero et al., 2013) that is
most similar to all the other conformers (i.e., the model in the
ensemble with the smallest average root-mean-square deviation
(rmsd) between it and all [other] models of the ensemble), and
designate it as the single representative NMR structure. The me-
doid model should be identified using only the well-defined res-
idue range(s). It can be computed using the algorithm described1566 Structure 21, 1563–1570, September 3, 2013 ª2013 Elsevier Ltby Tejero et al. (2013). For NMR structures containing multiple
domains that are ill defined with respect to one another, the
representative model should be chosen using this approach for
the largest domain. If the domains are of identical size, the repre-
sentative multidomain structure should be selected as the one
containing the domain resulting in the smallest rmsd. In addition,
the depositor may identify a depositor-designated representa-
tive structure as part of the deposition process, based on alter-
native criteria to be provided at the time of deposition. The
PDB might annotate the ‘‘medoid representative structure’’
and ‘‘depositor-designated representative structure’’ in order
to facilitate their use.
The ‘‘representative model’’ should also be annotated to
indicate which residues and/or atoms are well defined and
which are ill defined in the NMR ensemble, either on the basis
of the depositor-defined or the automatically generated desig-
nations as outlined in the previous sections. Specifically, the
information about atoms or residues being well or ill defined
should go into the PDB file of the structure and be distributed
by the wwPDB so as to be readily available to users and
external software. These annotations may be used by visualiza-
tion programs to color code or exclude ill-defined regions when
displaying the representative model(s). Such annotations will be
valuable to users of NMR structure coordinates, particularly
users who are not familiar with interpreting traditional ensemble
representations.
Knowledge-Based Protein Structure Validation. It is the
consensus of the NMR-VTF that knowledge-based model
validation of protein NMR structures, including covalent geome-
try, dihedral angle conformations, and core packing, should
utilize the same methods, software, and standards as those
recommended for the model validation of protein structures
determined by X-ray crystallography (Read et al., 2011). In
particular, MolProbity software (Chen et al., 2010) should be
used for analysis of overpacking (e.g., all-atom steric clashes)
and RosettaHoles software (Sheffler and Baker, 2009) for anal-
ysis of underpacking. Ramachandran backbone dihedral anal-
ysis should utilize recently updated parameters (Arendall et al.,
2005; Read et al., 2011).
Knowledge-based validation should be carried out on either
the automated or depositor-specified well-defined regions of
the structure outlined above. Global Z scores or percentiles,
which may be plotted as bar graphs as proposed for X-ray crys-
tal structures (Read et al., 2011; Gore et al., 2012), should be
reported only for well-defined regions of the structure, and
should be graded using the same set of structures used in
grading X-ray crystal structures (Gore et al., 2012). In particular,
users should be able to compare structures determined by X-ray
crystallography and by NMR using metrics and scales that are
common to X-ray and NMR structures.
Specifically, the NMR-VTF recommends that knowledge-
based validation scores be reported on two scales: (1) relative
to the entire protein crystal structure archive of the PDB (i.e.,
the same reference structures used for assessment of X-ray
crystal structures), and (2) relative to the NMR structure archive
of the PDB. However, implementers are encouraged to consider
alternate basis sets of structures to use in determining such
assessment statistics. Scores should be reported as first quar-
tile, mean, and third quartile.d All rights reserved
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for each residue of the structure. For such local model structure
validation, it is recommended to consider residues in both the
well-defined and ill-defined regions of the structure. By analogy
with X-ray structures, for which local structural information is
graded by the wwPDB by comparison with crystal structures
refined to similar diffraction resolutions, for NMR structures
this local structural information should be graded based on the
entire database of NMR structures. Although ill-defined regions
of the structure may or may not have energetically reasonable
conformations, depositors should be encouraged to model
these regions with plausible conformations. However, the final
decision regarding how to model regions of the structure that
are underconstrained by the experimental data should be left
to the experimentalists who have determined the NMR structure.
Validation of the Consistency between Experimental Restraints
and Structural Models. NMR structures also should be validated
against distance and dihedral restraint data that are submitted
as part of a PDB deposition. In phase 1, the NMR-VTF recom-
mends a simple model-versus-data validation of the structure
against only the submitted experimental restraints. These should
include (1) distance restraints, (2) hydrogen-bond restraints, (3)
dihedral angle restraints, and (4) any additional distance re-
straints provided with the PDB deposition. These restraint data
should be compared with the coordinates of each model to
determine restraint violations by each model. Nuclear Over-
hauser effect (NOE)-based distance-restraint violations should
be interpreted with the assumption of r6 summation for ambig-
uous restraints (Nilges, 1995). The numbers of intraresidue (i = j),
sequential (ji  jj = 1), medium-range (1 < ji  jj < 5), long-range
(ji  jj R 5), and interchain restraints should be summarized,
together with the number of restraints in each category (NOE-
based, hydrogen-bond, dihedral angle, etc.). The number of sca-
lar coupling, residual dipolar coupling, chemical shift anisotropy,
paramagnetic relaxation enhancement, and other restraint data
should also be summarized. The numbers of restraint violations,
in each class, should be reported in bins (e.g., 0–0.2 A˚, 0.2–0.5 A˚,
>0.5 A˚), along with the values of the largest restraint violations in
each restraint class. If appropriate, such NMR specific metrics
could be graded by comparison against the corresponding
values observed in all NMR structures in the PDB for which
such restraint data are available. These data should be summa-
rized for all the models in the ensemble in a concise format, as
well as for the individual models.
Standardized NMR Structure Validation Report. A standard
wwPDB NMR structure validation report should be developed.
The committee recommends that initially only a core set of stan-
dardized validation metrics be adopted. The report should
include a summary of the completeness of the chemical shift
data, including a summary of unusual chemical shift values,
alongwith a validation of the NMR structuremodels using knowl-
edge-based and restraint violation statistics. The report should
include a version number, along with raw scores generated by
the underlying knowledge-based structure validation software.
It should also include machine-readable output. These would
be expanded over time, as the NMR-VTF assesses and recom-
mends more sophisticated model-versus-data metrics.
Useful models of such reports are provided by the protein
structure validation software suite (PSVS) (Bhattacharya et al.,Structure 21, 1563–152007), CING software package (Doreleijers et al., 2012), and
PDBStat software (Tejero et al., 2013). A recently published
survey of NMR structure validation software (Vuister et al.,
2013) also provides useful guidance for the development of
NMR structure quality assessment reports. An example of an
NMRStructure Validation Report for Phase 1, including chemical
shift completeness statistics, restraint violation summaries and
statistics, and knowledge-based structure validation statistics,
taken from a recent paper (Aramini et al., 2012) is presented in
Table 1. This example is provided only as a guide to the kind of
concise summary that the wwPDB might include in their valida-
tion reports. Additional information, such as chemical shift vali-
dation statistics (Moseley et al., 2004), could also be provided.
Appropriate criteria will need to be developed for structures
refined from NOESY-derived distance restraints that do not
specify upper or lower bounds (Nilges, 1995). The X-ray crystal
structure validation reports described by Gore et al. (2012) also
provide useful examples to guide the design of a concise
wwPDB NMR validation report. In addition, more extensive
NMR structure validation data and graphical assessment tools,
similar to those provided for X-ray crystal structure validation re-
ports (Read et al., 2011), should be provided.
Phase 2. Methods and Software Exist but Require
Additional Assessment before Adopting Standard
Validation Conventions
A critical task for the NMR-VTF is to continue to assess model-
versus-data validation metrics that can be used to validate the
degree to which 3D NMR structures fit the underlying experi-
mental data; that is, ‘‘NMR R factors.’’ These model-versus-
data metrics could include assessment of scalar coupling, resid-
ual dipolar coupling (RDC), chemical shift anisotropy (CSA),
unassigned NOESY peak list, paramagnetic resonance
enhancement (PRE), paramagnetic pseudocontact shift, solid-
state dipolar coupling, and SAXS or SANS data. Several tools
for validating structures against these data are available,
including methods for validation of protein structures against
RDC data (Bryson et al., 2008; Clore et al., 1993; Valafar and Pre-
stegard, 2004), CSA data (Cornilescu et al., 1998), NOESY peak
lists (Bagaria et al., 2012; Huang et al., 2005, 2012; Nilges, 1995),
and SAXS data (Grishaev et al., 2005).
Although these methods are very powerful and generally
robust, they have not yet been uniformly adopted across the
biomolecular NMR community. Metrics based on these data
require clear definitions and further assessment, as well as a
process for harvesting these data by the wwPDB in an appro-
priate format for validation. For these reasons, the NMR-VTF
does not recommend including these model-versus-data met-
rics in standard wwPDB validation reports in phase 1.
During phase 2, the NMR-VTF will assess and then recom-
mend the software packages most suited to model-versus-
data validation. In order to provide an expanded NMR Structure
Validation Report in Phase 2, with additional model-versus-
data assessments, depositors of biomolecular NMR structures
are encouraged to archive (where available) in the Bio-
MagResBank (Ulrich et al., 2008) NOESY peak lists, RDC,
PRE, and SAXS or SANS experimental data, as well as unpro-
cessed free induction decay data, for biomolecular structures
deposited in the PDB.70, September 3, 2013 ª2013 Elsevier Ltd All rights reserved 1567
Table 1. Example of a Table Providing a Summary of Structural
Statistics Developed and Based on The Recommendations of the
NMR-VTF for Bacterial Protein Alr2454
Alr2454a
Completeness of resonance assignments (%)b
Backbone 99.4
Side chain 98.3
Aromatic 96.6
Stereospecific methyl 100
Conformationally restricting restraintsc
Distance restraints
Total 2,478
Intraresidue (i = j) 688
Sequential (ji  jj = 1) 619
Medium range (1 < ji  jj < 5) 462
Long range (ji  jjR 5) 709
Dihedral angle restraints 162
Hydrogen-bond restraints 0
Disulfide restraints 0
No. of restraints per residue 25.5
No. of long-range restraints per residue 6.8
Residual restraint violationsc
Average no. of distance violations per structure
0.1–0.2 A˚ 8.75
0.2–0.5 A˚ 1.85 (0.35 max)
>0.5 A˚ 0
Average no. of dihedral angle violations per structure
1–10 8.75 (3.8 max)
>10 0
Model qualityc
Rmsd backbone atoms (A˚)d 0.6
Rmsd heavy atoms (A˚)d 0.9
Rmsd bond lengths (A˚) 0.018
Rmsd bond angles () 1.1
MolProbity Ramachandran statisticsc,d
Most favored regions (%) 96.8
Allowed regions (%) 3.1
Disallowed regions (%) 0.1
Global quality scores (raw/Z score)c
Verify3D 0.40/0.96
ProsaII 0.66/0.04
PROCHECK (f-c)d 0.15/0.28
PROCHECK (all)d 0.03/0.18
MolProbity clash score 12.51/0.62
Model contents
Ordered residue rangesd 1–100
Total no. of residues 108
BMRB accession number 17965
PDB ID code 2LJWa
aStructural statisticscomputed for theensembleof 20depositedstructures.
bComputed using AVS software (Moseley et al., 2004) from the expected
number of resonances, excluding highly exchangeable protons (N-termi-
nal, Lys, amino and Arg guanido groups, hydroxyls of Ser, Thr, and Tyr),
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structures that have been deposited in the PDB and subse-
quently found to include some inaccuracies as valuable test
data sets useful for the development of structure validation
methods. Coordinates that have been designated by depositors
as ‘‘obsolete’’ that are archived in the PDB are also valuable for
testing and developing structure validation tools. The NMR-VTF
recommends that a set of such ‘‘inaccurate NMR structure coor-
dinates’’ is collected and provided to the community for methods
development.
Phase 3. Areas Requiring Additional Research
The NMR-VTF has identified the validation of NMR structures of
polynucleic acids, including DNA and RNA, and polysaccharides
as critical areas that require additional research. Although it is
likely that some of the same tools used for validating NMR struc-
tures of proteins and X-ray crystal structures of nucleic acids will
be appropriate for NMR structures of nucleic acids and polysac-
charides, the NMR-VTF has agreed to make standardization of
metrics for nucleic acid NMR structure validation a future priority
of the committee.
A key metric requiring further research is the validation of
structures in terms of the experimental information content of
the data on which they are based. This ‘‘information content
measure’’ would be analogous to the ‘‘resolution’’ measure so
central for X-ray crystal structures. For NMR, there could poten-
tially be both a global and a local version of such a measure. It
was generally agreed by the NMR-VTF that the metric of ‘‘re-
straints per residue,’’ although in the spirit of such an information
content measure, is not satisfactory, because different restraints
have different information content. In particular, the restraints
per residue metric do not correlate well with structural accuracy.
This is an important area of research.
Chemical shift data can also be used for validation of 3D bio-
molecular structures (Han et al., 2011; Rieping and Vranken,
2010; Shen and Bax, 2010). This is a significant motivation for
capturing chemical shift data for all protein and nucleic acid
structures deposited in the PDB. However, chemical shifts are
dominated by local effects and hence need to be combined
with other data sensitive to longer-range structural features as
part of a comprehensive model-versus-data quality assessment.
Although advances have been made in this high-impact area of
computational NMR, additional research is needed before stan-
dardized methods for validating structures directly against
chemical shifts can be recommended for inclusion in thewwPDB
NMR validation pipeline.
The NMR-VTF also recognized that biomolecular NMR data
generally are an ensemble average, with Boltzmann-weighted
contributions from the various conformers present in the sample.
Accordingly, the NMR data may not be best fit by a single
conformer. For this reason, it is critical to develop tools that
can be used to assess to what degree the lack of precision in
defining atomic coordinates is due to such underlying internalcarboxyls of Asp and Glu, nonprotonated aromatic carbons, and the
C-terminal His6 tag.
cCalculated using PSVS version 1.4 (Bhattacharya et al., 2007). Average
distance violations were calculated using the sum over r6.
dBased on ordered residue ranges [S(f) + S(c) > 1.8].
d All rights reserved
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tion, chemical shift, dipolar coupling, and/or residual dipolar
coupling data. Methods for generating ensembles of conformers
that best satisfy the experimental data (e.g., Clore and Schwi-
eters, 2004; Lindorff-Larsen et al., 2005), particularly in highly
dynamic regions of a structure, and validation of these ensem-
bles of conformers against the ensemble-averaged data, are
also an important area for future research.Conclusions
There is no a priori reason to believe that biomolecular structures
determined by NMR in solution or the solid state are fundamen-
tally different from those determined by X-ray crystallography,
even though intermolecular packing effects in the crystal lattice
may stabilize local conformations that are not predominant in so-
lution. For this reason, the knowledge-based validation of NMR
structures should be done using the same metrics and stan-
dards, and scaled against the same or comparable structural
data sets, as has been recommended for X-ray crystal structures
(Read et al., 2011). As there is no generally accepted information
content measure in NMR similar to a resolution, these knowl-
edge-based statistics should be reported relative to (1) all crystal
structures in the archive and (2) all NMR structures in the archive.
Model-versus-data validation of NMR structures is critical for
the maturation of the field of biomolecular NMR. However, the
recommendation of consensus statistics for model-versus-
data validation (i.e., NMR R factors) is complicated by the fact
that NMR structures are often derived from a large number of
different kinds of NMR data types. Quality assessment is simpli-
fied in these initial recommendations by focusing on restraint
violation analyses. However, the restraints are interpreted data,
which may not capture all of the information present in NOESY
spectra and other NMR data sets. Although methods are avail-
able to assess models against all these kinds of experimental
data, more work is needed to define standards and metrics
before incorporating these metrics into a wwPDB NMR valida-
tion pipeline. Hence, additional work will be needed to develop
standards and methods for a comprehensive model-versus-
data assessment.
Considering these caveats, software is available today to
generate a useful and extensive Phase 1 wwPDBNMR Structure
Validation Report. This report will include chemical shift data
validation (completeness and outliers), assessment of ‘‘well-
defined’’ and ‘‘ill-defined’’ regions of the structure, knowledge-
based validation of well-defined regions, and a comprehensive
validation of the structure against restraint data. Such reports
will provide valuable information on the precision and accuracy
of NMR structures useful for guiding biological research.
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